Presentation is loading. Please wait.

Presentation is loading. Please wait.

DVP II Life sciences & health 4-14 May 2014. 2 DVP Health & life sciences Objectives: Participants: 8 experts in healthcare & life sciences from different.

Similar presentations


Presentation on theme: "DVP II Life sciences & health 4-14 May 2014. 2 DVP Health & life sciences Objectives: Participants: 8 experts in healthcare & life sciences from different."— Presentation transcript:

1 DVP II Life sciences & health 4-14 May 2014

2 2 DVP Health & life sciences Objectives: Participants: 8 experts in healthcare & life sciences from different courtiers Experience the Netherlands first hand Gain insight into the country’s history, culture and people Obtain relevant knowledge and worthwhile contacts to satisfy personal and professional needs and interests Pursue mutually beneficial opportunities, leads, contacts, projects, etc., with Dutch individuals and organisations

3 3

4 4 Life Sciences in the Netherlands

5 5

6 6 8 University Medical Centers, 14 Research Universities (incl. 3 Technical Universities), 137 general hospitals Biobanks and patient cohorts for research purposes Life Sciences in the Netherlands

7 7

8 8 Dedicated Bio Science Park (since 1984) with a clear focus Specialisation in biomedical and bio molecular life sciences; biopharmaceutical production 90 life science companies with ± 3,800 employees ~16,000 employees in total working at 1 location LUMC with ± 6,800 employees in total another 6 academic/education centers with ± 2,600 employees in life science related jobs the largest number of life sciences start-ups 2 musea: Naturalis Biodiversity Center and Corpus Experience 2 skilled labour pools

9 Facilities Expat centre Naturalis Biodiversity Center Netherlands Centre for Electron Nanoscopy Biotech Training Facility Realistic biopharmaceutical plant, for training, education and demonstration Bridge gap between schooling and practice Location close to education institutes and industry Construction starts summer 2014, opening autumn 2015 Investment ~ € 10 M

10 Service companies  Proxy Laboratories: QA, QC, stability testing, assay development, validation  Microsafe Laboratories: microbiology testing  Galapagos: target discovery  Xendo: process development, drug development, validation, RA, GMP, pharmaceutical engineering, clinical trials, bio analytical service  Batavia Bioservices: early process development  OctoPlus/Dr. Reddy’s: drug delivery technology  TLC: drug delivery technology  TNO Quality of life: drug development  BaseClear: DNA sequencing, forensic support  CHDR: clinical trials  BioTop Medical: regulatory Affairs  ServiceXS: genomics service center  LifeScienceGo!: business resources  Chiltern: full clinical research services from early phase to late phase  Halix: CMO

11 11 Center for Human Drug Research www.chdr.nl

12 12 Center for Human Drug Research

13 13 Mission of both centres is to maximise effective utilisation of new IP (social, economic and financial drivers are relevant) Evaluate & protect new inventions Identify and negotiate licensees Assist in new company formation (mentoring, pre-seed & seed funds) Advise university on EU and other major research funding opportunities Negotiate research contracts, particularly complex public/private partnerships Leiden Technology Transfer Office Leiden University and Leiden University Medical Centre http://www.research.leiden.edu/luris/industry/

14 14

15 15 Institute for Health Policy and Management, Erasmus University

16 16 grantbmt@sk.ru


Download ppt "DVP II Life sciences & health 4-14 May 2014. 2 DVP Health & life sciences Objectives: Participants: 8 experts in healthcare & life sciences from different."

Similar presentations


Ads by Google